🔗 Visit the ClinicalTrials.gov page for NCT00602667
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections. | Cancer Chemother Pharmacol | 2014 | 1.78 |
| 2 | The rationale for targeted therapies in medulloblastoma. | Neuro Oncol | 2013 | 0.92 |
| 3 | Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss. | Nat Genet | 2015 | 0.83 |
| 4 | Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant. | Drug Metab Dispos | 2016 | 0.77 |
| 5 | Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature. | Clin Pharmacokinet | 2016 | 0.76 |
| 6 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |